Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/06 → 6/30/07 |
Funding
- Pfizer Inc.
Phase II Study of the Anti-Angiogenesis Agent AG-013736 as Second-or Later-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer
- Rinehart, John (PI)
- Arnold, Susanne (CoI)